PHARMA SIGNAL — Regulatory Intelligence Platform

PharmaSignal aggregates real-time regulatory intelligence from the FDA, EMA, MHRA, Health Canada, TGA, and NMPA. Track drug approvals, clinical trials, company pipelines, patent cliffs, and market data — all in one place.

This platform requires JavaScript to run. Please enable JavaScript in your browser.

Features

REGULATORY INTELLIGENCE PLATFORM
Global pharma signals,
decoded in real time.
Track FDA, EMA, and other global regulators. Monitor drug approvals, clinical trials, company pipelines and patent cliffs — all in one free platform built for investors and pharma professionals.
NO SIGNUP · NO ADS · NO PAYWALLS
5+
REGULATORS MONITORED
20K+
DRUGS IN DATABASE
300+
COMPANIES TRACKED
∞
FREE FOREVER
PLATFORM FEATURES
INTELLIGENCE FEED
Live regulatory signals from FDA, EMA, MHRA, Health Canada, TGA and NMPA — enriched with AI analysis, impact scores and risk flags.
DRUG LOOKUP
Search any active substance or INN across FDA Drugs@FDA and the EMA medicines register simultaneously. See approval status, application type and EMA product page.
COMPANY INTELLIGENCE
Company profiles with pipeline, patents, financials, market data, tariff exposure and linked regulatory signals — all in one view.
CLINICAL TRIALS
Filter and browse active trials by phase, status, therapy area and company. Linked directly to ClinicalTrials.gov.
TOP DRUGS & PATENT CLIFFS
Revenue-ranked drug table with growth rates, patent expiry dates and years remaining — sortable by revenue, growth or cliff proximity.
AI ENRICHMENT
Every signal runs through specialist agents — clinical, market, legal and manufacturing — each scoring confidence and flagging implications.
FOR INVESTORS
MARKET-MOVING INTELLIGENCE
  • FDA and global regulatory decisions, tracked in real time
  • Patent expiry timelines across your portfolio companies
  • Tariff exposure analysis by company and manufacturing region
  • Scored impact assessment for every regulatory event
  • Company financials and pipeline linked directly to regulatory signals
FOR PHARMA PROFESSIONALS
YOUR REGULATORY INTELLIGENCE LAYER
  • Competitor approval monitoring across major global regulators
  • Drug lookup across FDA and EMA databases simultaneously
  • Clinical trial tracking by therapy area, phase, and status
  • Exclusivity window and biosimilar entry point identification
  • Historical regulatory archive for precedent and comparative research
ABOUT
BUILT FOR THE INDUSTRY

PharmaSignal is a non-profit project created by Saman Salmasi — a law student with a background in pharmaceutical sciences and machine learning research for pre-clinical drug discovery — to build a free, all-in-one intelligence platform for pharma professionals and investors.

The pharma industry operates across many layers: regulatory decisions, clinical pipelines, patent timelines, market movements, and the forces shaping them. Understanding any one of them in isolation isn't enough. PharmaSignal brings these pieces together in one place, so the people who need to move fast across different layers of the industry actually can.

The platform is continuously improving. Upcoming areas of expansion include deeper pipeline analytics, biomarker and indication tracking, M&A and licensing activity, and broader global regulatory coverage. Suggestions, feedback, and ideas are always welcome — reach out directly at sam.salmasi.ss@gmail.com.

DATA SOURCES
FDA Food and Drug Administration UNITED STATES
EMA European Medicines Agency EUROPEAN UNION
MHRA Medicines & Healthcare products Regulatory Agency UNITED KINGDOM
HEALTH CANADA Drug & Health Products Directorate CANADA
TGA Therapeutic Goods Administration AUSTRALIA
CLINICALTRIALS.GOV U.S. National Library of Medicine UNITED STATES
PHARMA SIGNAL © 2025 · FOR INFORMATIONAL USE ONLY
NOT INVESTMENT OR MEDICAL ADVICE. ALL DATA SOURCED FROM PUBLIC REGULATORY DATABASES.